🍪 Cookies
We use analytics cookies (Google Analytics) to understand how you use the site. You can accept or reject them — the site works fully either way.
$TROL is a cryptoasset designed to fund real-world longevity research and supplement development. The project focuses on the combined potential of two well-known compounds, Resveratrol and Berberine, to promote healthspan and possibly extend human lifespan. Resveratrol, a compound found in red grapes and red wine, is commonly referred to as the “longevity molecule.” It has been studied for its potential role in cellular repair, anti-inflammatory processes, and age-related decline. Berberine, extracted from plants such as barberries, is known for its ability to support metabolic function, including blood sugar regulation and lipid metabolism. Both compounds are widely sold as over-the-counter supplements, with limited human trials confirming their long-term efficacy. $TROL aims to address this research gap by directing crypto trading fees toward controlled scientific studies. The experiments are conducted via Pump Science, a decentralized platform that enables rapid fundraising, streami
Resveratrol & Berberine (TROL) is a cryptocurrency that can be traded on various exchanges. It has a current market capitalization of $3,287, making it one of the notable digital assets in the crypto market.
The current price of Resveratrol & Berberine (TROL) is $0.00000339. Prices update in real-time based on market activity across major cryptocurrency exchanges.
You can buy Resveratrol & Berberine (TROL) on major cryptocurrency exchanges such as Binance, Coinbase, and Kraken. Always use a reputable exchange and enable two-factor authentication to secure your account.
Whether Resveratrol & Berberine is a good investment depends on your financial goals, risk tolerance, and research. Cryptocurrency markets are highly volatile. Always do your own research and consider consulting a financial advisor before investing.
Top cryptocurrencies with market capitalization closest to this coin.